Evidence map›Paper›PMID 33055113›Full record

ArticleBMJ open2020

Intermittent antegrade warm-blood versus cold-blood cardioplegia in children undergoing open heart surgery: a protocol for a randomised controlled study (Thermic-3).

Rachael Heys, Serban Stoica, Gianni Angelini, Richard Beringer, Rebecca Evans, Mohamed Ghorbel, William Lansdowne, Andrew Parry, Guido Pieles, Barnaby Reeves and 7 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Warm versus cold blood cardioplegia in paediatric congenital heart surgery: a randomized trial.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2023
    Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Rachael Heys *Bristol Trials Centre, Clincal Trials and Evaulation Unit, Bristol Medical School, University of Bristol, Bristol, UK rh13369@bristol.ac.uk.ORCID 0000-0002-3957-1287
Serban Stoica *Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Gianni AngeliniNational Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK.
Richard BeringerBristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Rebecca EvansBristol Trials Centre, Clincal Trials and Evaulation Unit, Bristol Medical School, University of Bristol, Bristol, UK.
Mohamed GhorbelBristol Heart Institue, University of Bristol, Bristol, UK.
William LansdowneBristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Andrew ParryBristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Guido PielesBristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Barnaby ReevesBristol Trials Centre, Clincal Trials and Evaulation Unit, Bristol Medical School, University of Bristol, Bristol, UK.ORCID 0000-0002-5101-9487
Chris RogersBristol Trials Centre, Clincal Trials and Evaulation Unit, Bristol Medical School, University of Bristol, Bristol, UK.
Rohit SaxenaCardiac Intensive Care, Great Ormond Street Hospital For Children NHS Foundation Trust, London, UK.
Karen SheehanNational Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK.
Stella SmithBristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
Terrie Walker-SmithBristol Trials Centre, Clincal Trials and Evaulation Unit, Bristol Medical School, University of Bristol, Bristol, UK.
Robert Mr TullohNational Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK.
Massimo CaputoBristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
University Hospitals Bristol NHS Foundation Trust · GBAt Bristol · GBGreat Ormond Street Hospital for Children NHS Foundation Trust · GBUniversity of Bristol · GB

Funding

British Heart Foundation CH/17/1/32804British Heart Foundation CH/1992027/7163British Heart Foundation PG/15/33/31394
6 · The paper itself

Abstract

introductionSurgical repair of congenital heart defects often requires the use of cardiopulmonary bypass (CPB) and cardioplegic arrest. Cardioplegia is used during cardiac surgery requiring CPB to keep the heart still and to reduce myocardial damage as a result of ischaemia-reperfusion injury. Cold cardioplegia is the prevalent method of myocardial protection in paediatric patients; however, warm cardioplegia is used as part of usual care throughout the UK in adults. We aim to provide evidence to support the use of warm versus cold blood cardioplegia on clinical and biochemical outcomes during and after paediatric congenital heart surgery. METHODS AND ANALYSIS: We are conducting a single-centre randomised controlled trial in paediatric patients undergoing operations requiring CPB and cardioplegic arrest at the Bristol Royal Hospital for Children. We will randomise participants in a 1:1 ratio to receive either 'cold-blood cardioplegia' or 'warm-blood cardioplegia'. The primary outcome will be the difference between groups with respect to Troponin T levels over the first 48 postoperative hours. Secondary outcomes will include measures of cardiac function; renal function; cerebral function; arrythmias during and postoperative hours; postoperative blood loss in the first 12 hours; vasoactive-inotrope score in the first 48 hours; intubation time; chest and wound infections; time from return from theatre until fit for discharge; length of postoperative hospital stay; all-cause mortality to 3 months postoperative; myocardial injury at the molecular and cellular level. ETHICS AND DISSEMINATION: This trial has been approved by the London - Central Research Ethics Committee. Findings will be disseminated to the academic community through peer-reviewed publications and presentation at national and international meetings. Patients will be informed of the results through patient organisations and newsletters to participants. TRIAL REGISTRATION NUMBER: ISRCTN13467772; Pre-results.

Indexed as

Cardiac Surgical ProceduresHeart Defects, CongenitalAdultCardiopulmonary BypassChildHeart Arrest, InducedHumansLondonRandomized Controlled Trials as Topiccardiac surgeryclinical trialscongenital heart diseasepaediatric cardiothoracic surgeryprotocols & guidelines

Identifiers

PMID33055113
PMCPMC7559029
OpenAlexW3093420727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.